Andrew Hore

Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.

Crystal Amber plan to revitalise Hurricane Energy

AIM movers: MS International new weapon sale and Gfinity loss

City of London Group liquidation and distribution of Recognise Bank shares

Braveheart Investment cuts Velocity Composites stake

Journeo acquisition increases exposure to rail sector

Strong trading at NWF plus infill fuels acquisition

AIM movers: Tekmar contract and ex-dividends

New standard listing: Medcaw Investments seeks wellness acquisition

AIM movers: Image Scan rises, but ScotGold Resources reduces production guidance

AIM movers: Velocity Composites $100m US contract and potential bid for Xpediator

Serica Energy expands in North Sea

Purplebricks fights off attempt to remove chairman

AIM movers: Midateach Pharma revises funding terms and Star Phoenix has no auditor

Aquis weekly movers: Hydrogen Utopia International moving to standard list

AIM weekly movers: RUA Life Sciences bounces back

AIM movers: Time Finance profit recovery and proposed Dev Clever delisting hits Asimilar

New AIM admission: Smarttech247

Lockdowns in China hold back Samarkand

K3 Capital recommends bid

SkinBioTherapeutics raising up to £3.5m

AIM movers: PetroTal rebuilds oil production as river blockade ends and ex-dividends

CyanConnode hopes for strong second half

AIM movers: Billington builds momentum and Trackwise Designs desperate need for cash

Why companies left AIM in October and November

Helium One Global funds exploration well

Higher levels of insolvencies propel Begbies Traynor

Savannah Energy finally completes ExxonMobil deal

AIM movers: Blackbird partnership paying off and PCF departing

Record share trading at Hamak Gold

AIM movers: RUA Life Sciences share price gains heart and Engage XR contract delays

Xpeng – the Tesla rival whose shares have rallied 315% in two months

23/11/2020

‘End of Austerity’ promise hashed out during PMQs

10/10/2018

Brexit: 5,000 City jobs could leave UK

10/10/2018

Advanced Oncotherapy shares soar after cancer treatment milestone

10/10/2018

Two reasons Travelodge backers can expect sleepless nights

24/07/2020